IN-DATE
5F051503CS: Bard LifeStent 5F Vascular Stent System 5mm x 150mm, 135cm
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $999.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 1 box of 1 |
| Expiration: | 05-2028 |
| Express: | Need it tomorrow? Order in next 16 hours 32 minutes and choose overnight shipping at checkout. |
Additional Details
BD Bard LifeStent 5F
- Unique helical design engineered for bending, compression, torsion
- Low profile, 5F delivery system
- Dual-speed thumbwheel deployment designed for ease of use and placement accuracy
- GEOALIGN® Marking System designed to increase procedural efficiency and reduce radiation exposure
AccessGUDID Info
- FDA Product Code: NIP
- FDA Product Code Name: STENT, SUPERFICIAL FEMORAL ARTERY
- GMDN Term Code: 47932
- GMDN Term Name: Peripheral artery stent, bare-metal
- GMDN Term Description: A non-bioabsorbable tubular device intended to be implanted in a peripheral artery (excludes aorta, coronary, pulmonary, and intracranial arteries) to indefinitely maintain patency and improve luminal diameter in patients with atherosclerotic disease, or following the recanalization of a total occlusion. It may additionally be intended to be implanted in an obstructed biliary duct; it is not dedicated to carotid artery implantation, and not intended for connection with an aortic stent. It is made entirely of metal [e.g., Nitinol alloy mesh structure] and typically implanted by a dedicated instrument where it self-expands upon release or is balloon expanded.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
